JOHN, STRANG,ALEXANDER, OKSCHE,STEPHEN, HARRIS,KEVIN, SMITH,LUCIE HELENE JEANNE, MOTTIER
申请号：
TR201802716
公开号：
TR201802716T4
申请日:
2012.05.11
申请国别(地区):
TR
年份:
2018
代理人:
摘要：
abstract the present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to = 0.5 mg naloxone hcl dissolved in an application fluid of a volume of = 250 µl. furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and / or at least one symptom thereof. patent translation: "intranasal pharmaceutical dosage forms comprising naloxone". The present invention relates to an intranasal pharmaceutical dosage form comprising a dosage unit comprising naloxone or a pharmaceutically acceptable salt thereof in an equivalent amount = 0.5 mg hcl naloxone dissolved in a one volume delivery fluid. = 250 µl. further, the present invention relates to such intranasal pharmaceutical dosage form for use in treating opioid overdose and / or at least one symptom thereof.Mevcut buluş, = 250 µl uygulama akışkan hacminde çözünmüş = 0.5 mg nalokson HCl'ye denk bir miktarda nalokson veya bunların farmakolojik olarak kabul edilebilir bir tuzunu içeren bir dozlama birimine sahip bir intranazal farmasötik dozaj formu ile ilgilidir. Buna ek olarak, mevcut buluş, opioid doz aşımı tedavisinde ve/veya bunların en az bir semptomunda kullanılması için bu gibi bir intranazal farmasötik dozaj formu ile ilgilidir.
